Zobrazeno 1 - 10
of 163
pro vyhledávání: '"Ami N Shah"'
Autor:
Ami N Shah, Lisa Flaum, Irene Helenowski, Cesar A Santa-Maria, Sarika Jain, Alfred Rademaker, Valerie Nelson, Dean Tsarwhas, Massimo Cristofanilli, William Gradishar
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
Background Response rates to single agent immune checkpoint blockade in unselected pretreated HER2−negative metastatic breast cancer (MBC) are low. However, they may be augmented when combined with chemotherapy.Methods We conducted a single-arm, ph
Externí odkaz:
https://doaj.org/article/8f13f23e68dd4f8e940351b6de1ccf17
Autor:
Jamie Harris, Jennifer Poirier, Debra Selip, Srikumar Pillai, Ami N Shah, Carl-Christian Jackson, Bill Chiu
Publikováno v:
Journal of Neonatal Surgery, Vol 4, Iss 3 (2015)
Objectives: Gastroschisis is a congenital anomaly affecting 2.3-4.4/10,000 births. Previous studies show initiation of early enteral feeds predicts improved outcomes. We hypothesize that earlier definitive closure after silo placement; can lead to ea
Externí odkaz:
https://doaj.org/article/c0602547015d444fb17640fce2c6a653
Autor:
Lorenzo Gerratana, Andrew A. Davis, Marko Velimirovic, Katherine Clifton, Whitney L. Hensing, Ami N. Shah, Charles S. Dai, Carolina Reduzzi, Paolo D’Amico, Firas Wehbe, Arielle Medford, Seth A. Wander, William J. Gradishar, Amir Behdad, Fabio Puglisi, Cynthia X. Ma, Aditya Bardia, Massimo Cristofanilli
Publikováno v:
Breast Cancer Research, Vol 25, Iss 1, Pp 1-12 (2023)
Abstract Background although being central for the biology and druggability of hormone-receptor positive, HER2 negative metastatic breast cancer (MBC), ESR1 and PIK3CA mutations are simplistically dichotomized as mutated or wild type in current clini
Externí odkaz:
https://doaj.org/article/e709c732d873422f9a1a421cdc570023
Autor:
Gwyneth A. Sullivan, John Sincavage, Audra J. Reiter, Andrew J. Hu, Melissa Rangel, Charesa J. Smith, Ethan M. Ritz, Ami N. Shah, Brian C. Gulack, Mehul V. Raval
Publikováno v:
Journal of Surgical Research. 288:1-9
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::300da1a1a38ab6c9a921dc77616d1317
https://doi.org/10.1016/j.jss.2023.02.033
https://doi.org/10.1016/j.jss.2023.02.033
Autor:
Michael D. Williams, Gwyneth A. Sullivan, Neha Nimmagadda, Brian C. Gulack, Mary Beth Madonna, Dana M. Hayden, Henry Govekar, Ami N. Shah
Publikováno v:
Diseases of the Colon & Rectum. 66:e224-e227
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ccd15ff2640eab4b88ce6155c4b300e0
https://doi.org/10.1097/dcr.0000000000002745
https://doi.org/10.1097/dcr.0000000000002745
Autor:
Ami N. Shah, Bora Lim, Monica M. Mita, Elizabeth Mauer, Kayla V. Layng, Calvin Chao, Adam M. Brufsky
Publikováno v:
Cancer Research. 83:P2-23
Background: Recent studies suggest differences in outcomes among patients (pts) with metastatic breast cancer (MBC) treated with abemaciclib, ribociclib, or palbociclib, but whether these differences have a genomic basis is unknown. Here, we utilize
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::71b534efb1cfec75d470c9e971d1d50d
https://doi.org/10.1158/1538-7445.sabcs22-p2-23-12
https://doi.org/10.1158/1538-7445.sabcs22-p2-23-12
Autor:
Carolina REDUZZI, Lorenzo Gerratana, Youbin Zhang, Maroua MANAI, Paolo D’Amico, Andrew A. Davis, Jeannine Donahue, Ami N. Shah, Massimo Cristofanilli
Publikováno v:
Cancer Research. 83:P2-26
Background: Circulating tumor cells (CTCs) in breast cancer (BC) are commonly defined as epithelial cells (EPCAM and cytokeratin (CK) positive), lacking the universal blood cell marker CD45. Nonetheless, CTCs expressing both CK and CD45 (= dual-posit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::66f29fa56caa381876ce197657b84dc3
https://doi.org/10.1158/1538-7445.sabcs22-p2-26-06
https://doi.org/10.1158/1538-7445.sabcs22-p2-26-06
Autor:
Neelima Vidula, Senthil Damodaran, Erica L. Blouch, Nora Horick, Nathan Royce Ruffle-Deignan, Manali Bhave, Ami N. Shah, Leticia Varella, Vandana Abramson, Joseph Sparano, Leif Ellisen, Ishraq Alim, Harry Ostrer, Hope Rugo, Aditya Bardia
Publikováno v:
Cancer Research. 83:OT1-11
Background: PARP inhibitors are currently approved for the treatment of germline BRCA1/2 mutant metastatic breast cancer (MBC), which accounts for 5-10% of breast cancer. We hypothesize that a PARP inhibitor may also have efficacy in somatic BRCA1/2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e3234158f19bb1061d1102374148b3a3
https://doi.org/10.1158/1538-7445.sabcs22-ot1-11-01
https://doi.org/10.1158/1538-7445.sabcs22-ot1-11-01
Autor:
Gwyneth A Sullivan, Hayley J Petit, Audra J Reiter, Jennifer C Westrick, Andrew Hu, Jennifer B Dunn, Brian C Gulack, Ami N Shah, Richard Dsida, Mehul V Raval
Publikováno v:
Journal of the American College of Surgeons. 236:411-423
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::54688287845ae9cd35d38af1fadafa96
https://doi.org/10.1097/xcs.0000000000000478
https://doi.org/10.1097/xcs.0000000000000478
Autor:
Grant S. Owen, Gwyneth A. Sullivan, Nicholas J. Skertich, Srikumar Pillai, Mary Beth Madonna, Ami N. Shah, Brian C. Gulack
Publikováno v:
Journal of Surgical Research. 278:132-139
Recurrent primary spontaneous pneumothorax (PSP) is often managed with a wedge resection (or blebectomy) and either pleurectomy or pleurodesis. There is a conflicting data regarding which approach is superior to reduce recurrence. Our objective is to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4de8500950088b95a414044bc65c6ca
https://doi.org/10.1016/j.jss.2022.03.028
https://doi.org/10.1016/j.jss.2022.03.028